GeoVax Labs, Inc.

GOVX · Nasdaq · SIC 2834: Pharmaceutical Preparations
397
SEC Filings

Business Summary

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers. Its lead program, GEO-CM04S1, is a next-generation COVID-19 vaccine based on Modified Vaccinia Ankara (MVA) vector technology, currently in multiple Phase 2 trials and a BARDA-funded Phase 2b trial. Other programs include Gedeptin for head and neck cancer, GEO-MVA for Mpox/smallpox, and preclinical vaccines for Ebola, Marburg, and Zika.

Next Earnings

Q2 FY2026 — expected 2026-09-22

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGOVXdiscussed_in_filing Cybersecurity
topic_mentionGOVXdiscussed_in_filing Trusted Computing
topic_mentionGOVXdiscussed_in_filing Blockchain & Crypto
topic_mentionGOVXdiscussed_in_filing Regulation
topic_mentionGOVXdiscussed_in_filing Automotive
topic_mentionGOVXdiscussed_in_filing Healthcare & Bio
topic_mentionGOVXdiscussed_in_filing Platform & Ecosystem
topic_mentionGOVXdiscussed_in_filing Sovereign & Government
topic_mentionGOVXdiscussed_in_filing Cybersecurity
topic_mentionGOVXdiscussed_in_filing Trusted Computing
topic_mentionGOVXdiscussed_in_filing Blockchain & Crypto
topic_mentionGOVXdiscussed_in_filing Regulation
topic_mentionGOVXdiscussed_in_filing Automotive
topic_mentionGOVXdiscussed_in_filing Healthcare & Bio
topic_mentionGOVXdiscussed_in_filing Platform & Ecosystem
topic_mentionGOVXdiscussed_in_filing Sovereign & Government
topic_mentionGOVXdiscussed_in_filing Cybersecurity
topic_mentionGOVXdiscussed_in_filing Trusted Computing
topic_mentionGOVXdiscussed_in_filing Blockchain & Crypto
topic_mentionGOVXdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-272024-12-310001437749-25-009614EDGAR40K words
2024-02-292023-12-310001437749-24-006086EDGAR—
2023-03-232022-12-310001437749-23-007636EDGAR—
2022-03-092021-12-310001437749-22-005677EDGAR—
2021-03-232020-12-310001437749-21-006906EDGAR—
2020-03-242019-12-310001437749-20-006029EDGAR—
2019-03-262018-12-310001437749-19-005682EDGAR—
2018-03-232017-12-310001437749-18-005301EDGAR—
2017-03-242016-12-310001437749-17-005201EDGAR—
2016-03-162015-12-310001437749-16-027776EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034811EDGAR12K words
2025-07-282025-06-300001437749-25-023651EDGAR—
2025-05-012025-03-310001437749-25-014083EDGAR—
2024-11-122024-09-300001437749-24-034530EDGAR—
2024-08-062024-06-300001437749-24-024867EDGAR—
2024-05-142024-03-310001437749-24-016605EDGAR—
2023-11-082023-09-300001437749-23-030926EDGAR—
2023-08-092023-06-300001437749-23-022775EDGAR—
2023-05-042023-03-310001437749-23-012551EDGAR—
2022-11-092022-09-300001437749-22-026579EDGAR—
2022-08-032022-06-300001437749-22-018639EDGAR—
2022-04-272022-03-310001437749-22-009862EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001437749-26-010733EDGAR9K words
2026-02-170001437749-26-004392EDGAR—
2026-01-120001437749-26-001113EDGAR—
2025-12-220001437749-25-038547EDGAR—
2025-11-260001437749-25-036447EDGAR—
2025-11-130001437749-25-034903EDGAR—
2025-09-300001437749-25-030125EDGAR—
2025-08-010001437749-25-024389EDGAR—
2025-07-290001437749-25-023689EDGAR—
2025-07-020001437749-25-021990EDGAR—

397 total filings indexed. 365 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

infectious-disease-vaccines oncology-immunotherapy immunocompromised-patient-vaccines biodefense-vaccines modified-vaccinia-ankara-(mva)-viral-vector-platform fda-priority-review-voucher-program-eligibility orphan-drug-status

Company Identity

CIK0000832489
TickerGOVX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 74964b298427eeb6c83a750ad8752622e357bb04ad53dc394dc95fd306ee8fc7
parent: 21d756723e415ea357f98ff0b0dcff958ceaffc97c7b0b2a9fc8aa143383ccd6
content hash: 7d140a5ae9c589941d51c3a457524160f61d537b2599e455a24b07f2886caf8e
signed: 2026-04-13T04:45:20.841Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf